MedTrace Logo

Turtle Therapy on HbA1c and Self-Efficacy Levels With Type 2 Diabetes

NCT07298837 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2025-12-23

No results posted yet for this study

Summary

This study examined the effect of live and video turtle therapy on hemoglobin A1c tests and self-efficacy levels in adults with Type 2 Diabetes Mellitus for the first time using pre-test and post-test methods.

Conditions

Interventions

BEHAVIORAL

Live Turtle Therapy (Pet therapy)

The individuals were asked to take on the responsibility of caring for the turtles. The patients in this group were given one turtle and the necessary materials (aquarium, food, aquarium sand, etc.) for 12 weeks. Within this scope, patients fed the turtles twice a day, once in the morning (08:00) and once in the evening (20:00), and changed the water in the aquarium every two days with water that had been kept at room temperature beforehand. In addition, they were asked to spend 20 minutes a day with the turtle. During the twelve-week (3-month) period in which the individuals took responsibility for turtle care, the "Turtle Monitoring Form" was administered by the executor to evaluate the time spent with the turtle and the implementation of practices related to how they performed turtle care.

BEHAVIORAL

Video Turtle Therapy (Pet therapy)

In addition, the consultant faculty member provided approximately 15 minutes of face-to-face information to patients regarding watching the turtle videos. Patients in this group were asked to watch documentaries featuring turtle videos for at least 20 minutes a day for twelve weeks. The "Turtle Viewing Form" was administered by the researcher to determine how many minutes per day the individuals watched the turtle videos.

Sponsors & Collaborators

  • Gümüşhane Universıty

    collaborator OTHER

  • Karadeniz Technical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-18
Primary Completion
2024-08-01
Completion
2024-11-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07298837 on ClinicalTrials.gov